论文部分内容阅读
目的观察斯奇康注射液治疗儿童反复呼吸道感染的疗效和不良反应。方法96例反复呼吸道感染患儿分为两组,治疗组49例,对照组47例。两组均予抗感染、平喘、抗炎等对症常规治疗。治疗组在常规治疗基础上肌内注射斯奇康注射液2个疗程:第1个疗程隔日1次,每次0.5 mg,共18次;第2个疗程每周2次,每次0.5 mg,共18次。两组在治疗前和治疗结束满半年时,分别查血清IgA、IgG、IgM。结果治疗组应用斯奇康注射液治疗后呼吸道感染次数明显减少,总有效率79.6%,对照组总有效率42.6%,两组比较,差异有统计学意义(P<0.01);治疗组血清IgA、IgG治疗后较对照组有明显升高,差异有统计学意义(P<0.01)。在斯奇康注射液治疗和观察期间均未发生不良反应。结论斯奇康注射液治疗儿童反复呼吸道感染安全、有效。
Objective To observe the efficacy and adverse reactions of schizophrenic injection in children with recurrent respiratory tract infections. Methods 96 cases of children with recurrent respiratory tract infection were divided into two groups: 49 cases in the treatment group and 47 cases in the control group. Both groups were anti-infective, anti-asthma, anti-inflammatory and other symptomatic routine treatment. The treatment group received 2 courses of intramuscular injection of siconazole intramuscularly on the basis of routine treatment: the first course was given once every other day for 0.5 times for 18 times; the second course was twice weekly for 0.5 mg each time, A total of 18 times. Serum IgA, IgG and IgM were detected in both groups before treatment and at the end of treatment six months. Results In the treatment group, the number of respiratory infections was significantly reduced after treatment with STK. The total effective rate was 79.6%, while the total effective rate was 42.6% in the control group. There was significant difference between the two groups (P <0.01) , IgG after treatment than the control group was significantly increased, the difference was statistically significant (P <0.01). No adverse reactions occurred during the treatment and observation of STQ. Conclusion Schcondkom injection in children with recurrent respiratory tract infection is safe and effective.